Acclaro Medical Revenue and Competitors

Founded in 2018 by world-class industry experts and top physicians in the nation, Acclaro Corporation is a US-based, VC-backed, fast-growing medical device company committed to innovating and developing game-changing solutions to address today’s most challenging unmet needs in the global medical aesthetic, ophthalmic and surgical markets.\n\nAcclaro’ s flagship product, UltraClear™ is the world’s first and only cold, ablative fiber laser platform, a breakthrough painless anti-aging solution and the first ablative laser not requiring topical numbing for most treatments. Powered by the revolutionary MIRACL™ and 3DIntelliPulse™ technologies, UltraClear™ is a high-speed, all-skin-type and all-in-one platform with unparalleled energy control capabilities, offering a full range of skin rejuvenation outcomes from true painless and zero-downtime anti-aging lunchtime treatments to most advanced collagen remodeling with superior results, 15-min avg. treatment time and the utmost patient safety and comfort.